Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Black cumin (Nigella sativa) seeds contain thymoquinone as the principal bioactive compound, which suppresses pro-inflammatory signaling through NF-κB and IRAK/AP-1 pathway inhibition while simultaneously activating Nrf2-mediated antioxidant defenses (SOD, CAT, glutathione peroxidase), as comprehensively validated in a 2021 Nutrients review of its molecular pharmacology (PMID: 34073784). Clinical trials demonstrate significant lipid-lowering, immunomodulatory, glycemic-regulating, and thyroid-supportive effects—including improved thyroid status and reduced VEGF-1 in Hashimoto's thyroiditis patients in a randomized controlled trial (PMID: 27852303).
Reported Benefits (Provisional)
Origin & History
Black Cumin (Nigella sativa) is an annual flowering plant native to South Asia, the Middle East, and North Africa, now cultivated globally in arid and semi-arid climates. Its seeds are revered for a rich spectrum of bioactive compounds. In functional nutrition, Black Cumin is highly valued for its potent immune-modulating, anti-inflammatory, and metabolic-regulating properties.
Research Narrative (Provisional)
A comprehensive 2021 review in Nutrients (Hannan et al., PMID: 34073784) synthesized extensive in vitro, animal, and human clinical data confirming thymoquinone's antioxidant, anti-inflammatory, anticancer, and cardioprotective properties across multiple molecular pathways. A 2024 review in the International Journal of Molecular Sciences (Alberts et al., PMID: 39769174) further catalogued Nigella sativa's therapeutic potential across cardiovascular, metabolic, respiratory, and neurological domains, noting dose-dependent efficacy in human trials. A randomized controlled trial published in BMC Complementary and Alternative Medicine (Farhangi et al., 2016, PMID: 27852303) demonstrated that Nigella sativa supplementation significantly improved thyroid function, reduced serum VEGF-1 and Nesfatin-1, and decreased body weight in Hashimoto's thyroiditis patients. A 2022 regulatory toxicology assessment (Burdock et al., PMID: 34838871) evaluated black cumin's safety profile as a food ingredient, concluding it is generally recognized as safe at customary dietary doses while identifying areas requiring further long-term safety data.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: Omega-6 (linoleic acid) and Omega-9 (oleic acid) fatty acids, saponins - Vitamins: Vitamin A, Vitamin C, Vitamin E - Minerals: Iron, zinc, magnesium, calcium - Phytochemicals: Thymoquinone, nigellone, alkaloids, polyphenols, flavonoids, sterols, terpenes
Reported Mechanism (Provisional)
Thymoquinone, the primary quinone in Nigella sativa volatile oil, inhibits the IRAK/AP-1/NF-κB signaling cascade, thereby suppressing production of pro-inflammatory cytokines TNF-α, IL-6, IL-1β, and COX-2-derived prostaglandins. Concurrently, it activates the Nrf2/ARE pathway to upregulate endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and heme oxygenase-1 (HO-1), counteracting oxidative stress at the transcriptional level. Thymoquinone also disrupts PI3K/AKT/mTOR signaling and induces apoptosis via caspase-3/9 activation in cancer cell lines, while modulating AMPK to enhance insulin sensitivity and hepatic lipid metabolism. Additional bioactives—thymohydroquinone, thymol, carvacrol, and p-cymene—contribute synergistic antimicrobial and bronchodilatory effects through calcium channel antagonism and mast cell stabilization.
Clinical Narrative (Provisional)
Research consists primarily of in vitro and animal studies with limited large-scale human clinical trials providing quantified outcomes. Rat studies using 500 mg/kg/day ethanolic extract demonstrated reduced lipid peroxidation and elevated SOD activity. Human clinical evidence remains limited despite extensive preclinical validation of thymoquinone's therapeutic effects. Most clinical claims are extrapolated from animal models rather than robust human randomized controlled trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.